Developers: | Johnson & Johnson |
Date of the premiere of the system: | December, 2019 |
Branches: | Pharmaceutics, medicine, health care |
2019: Release of the device for treatment of ear infections
At the beginning of December, 2019 the Johnson & Johnson company provided the device for treatment of recurrent ear infections at adults and children. It received the name Tubes Under Local Anesthesia (Tula).
Usually medicines of the first line for treatment of ear infections are antibiotics, but at synchronization of an incurable infection the next step is installation of a tube which allows to ventilate a middle ear and prevents fluid accumulation behind an eardrum. Usually this procedure requires the general anesthesia in hospital or the surgical center.
The Tula system for ENT organs is the first system of installation of timpanostomichesky tubes which can be used at small children only under local anesthesia in an office of the general practitioner. The solution is from anesthetic, the timpanichesky tubes and elements used for delivery of medicines and tubes to an eardrum.
A system uses small electric discharge to direct anesthetic to an eardrum before installation of a tube. Comparative simplicity of device insertion should increase availability of this option of treatment, said in the statement of the director of the Center of radiological devices Jeff Shuren.
The company received green light on release of the device, having known the results of clinical trial of 222 patients of children's age where underwent installations of timpanichesky tubes successfully at 86% of children 5 years are younger. At patients aged from 5 up to 12 years this indicator was 89%. The device can be used at children aged from 6 months and it is forbidden to application only for patients with an allergy to certain local anesthetics or with a perforated eardrum. [1]